Search results
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
LiveScience· 1 day agoIn an extremely rare case, a patient who received a cell-based cancer treatment later developed a...
Lung-targeted CRISPR therapy offers hope for cystic fibrosis
New Scientist· 2 days agoA CRISPR gene-editing therapy has the potential to offer an effective, long-lasting treatment for...
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study
US News & World Report· 2 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that the immunotherapy will create secondary cancers, a new study finds. The U.S ...
Affimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoAffimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript June 12, 2024 Affimed N.V. beats...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 2 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
Only 1 in 20 animal studies results in treatments approved for humans
UPI· 3 hours agoOnly 5% of therapies tested in animals wind up being approved by regulators for human use, according...
Kairos Pharma, Ltd. Plans $6 Million IPO for Week of June 17th (KAPA)
ETF DAILY NEWS· 2 days agoKairos Pharma, Ltd. (KAPA) expects to raise $6 million in an initial public offering (IPO) on the...
How personalized cancer vaccines could keep tumours from coming back
Nature· 4 days agoThe same mRNA technology that quickly brought the world a vaccine for COVID-19 is now showing...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Science Daily· 3 days agoIn November 2023, the FDA issued a warning about a risk of secondary cancers -- particularly blood cancers -- that may be associated with CAR-T cell therapy. The warning was ...
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
InvestorPlace· 1 day agoFundamentally, biotech stocks to buy operate on a clear and unavoidable narrative: wealth means...